We investigated the effect of selective opiate antagonists on striatal acetylcholine (ACh) and dopamine (DA) release. The mu-receptor antagonist beta-funaltrexamine (beta-FNA), the delta-antagonist naltrindole (NTI), and the kappa-antagonist norbinaltorphimine (nor-BNI) were used to selectively block different subtypes of opiate receptors. The experiments were carried out on isolated superfused striatal slices of rats, loaded with [3H]choline or [3H]dopamine. beta-FNA and NTI significantly enhanced the electrical field stimulation-evoked release of ACh but only if the dopaminergic input had been impaired either by chemical denervation or D2 dopamine receptor blockade. By contrast, neither the selective nor nonselective antagonists had any modulatory effect on the release of dopamine. It is concluded, therefore, that the release of ACh is tonically controlled by endogenous opioid peptide(s) through the stimulation of mu- and delta-opiate receptors located on cholinergic axon terminals, in addition to the tonic control by DA.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0361-9230(92)90070-eDOI Listing

Publication Analysis

Top Keywords

selective opiate
8
opiate antagonists
8
antagonists striatal
8
striatal acetylcholine
8
dopamine release
8
release ach
8
release
5
dopamine
4
acetylcholine dopamine
4
release investigated
4

Similar Publications

Article Synopsis
  • The study investigates the quality of life (QoL) perceptions among long-term methadone-dependent patients (MDPs) undergoing methadone maintenance treatment (MMT) for opioid use disorder (OUD).
  • Using qualitative methods, the research involved in-depth interviews with 25 MDPs to explore their experiences and satisfaction in various life aspects post-treatment.
  • Key findings revealed themes of improved physical and mental health, a sense of purpose in life, positive self-perception, enhanced social support, marital satisfaction, and challenges related to fatigue, stigma, and financial strain associated with MMT.
View Article and Find Full Text PDF

Original Research: Is Your Outpatient Office Prepared to Manage an Opioid Overdose?

Am J Nurs

January 2025

Nancy S. Goldstein is an assistant professor at the Johns Hopkins University School of Nursing in Baltimore, MD, where Claire Grubb is a graduate nurse. Contact author: Nancy S. Goldstein, . The authors and planners have disclosed no potential conflicts of interest, financial or otherwise.

Background: Outpatient facilities, such as family and adult practice offices, psychiatric offices, and substance use treatment centers, should be equipped to manage medical emergencies and facilitate hospital transfers. Clinics that treat patients with opioid use disorder must be especially prepared to address respiratory arrest due to opioid overdose.

Purpose: The objective of this integrative review was to identify emergency response initiatives already investigated or developed that could be adapted to address opioid-related medical emergencies in the outpatient adult treatment setting.

View Article and Find Full Text PDF

Introduction: This paper outlines the steps necessary to assess the latest developments in artificial intelligence (AI) as well as Big Data technologies and their relevance to the opioid crisis. Fatal opioid overdoses have risen to over 82 998 annually in the USA. This highlights the need for urgent and effective data-driven solutions.

View Article and Find Full Text PDF

The opioid system plays crucial roles in modulating social behaviors in both humans and animals. However, the pharmacological profiles of opioids regarding social behavior and their therapeutic potential remain unclear. Multiple pharmacological, behavioral, and immunohistological c-Fos mapping approaches were used to characterize the effects of μ-opioid receptor agonists on social behavior and investigate the mechanisms in naive mice and autism spectrum disorder-like (ASD-like) mouse models, such as prenatally valproic acid-treated mice and Fmr1-KO mice.

View Article and Find Full Text PDF

Activity-related dyspnea and exercise intolerance in chronic obstructive pulmonary disease: recent insights.

Curr Opin Pulm Med

December 2024

Respiratory Investigation Unit, Division of Respirology, Department of Medicine, Queen's University, Kingston, Ontario, Canada.

Article Synopsis
  • The review focuses on understanding exertional dyspnea and exercise intolerance in chronic obstructive pulmonary disease (COPD) to enhance treatment strategies.
  • Recent studies emphasize the relationship between ventilatory demand and capacity, highlighting the effects of the brain on symptom perception and emotional response.
  • Successful management of dyspnea involves combining drug treatments and personalized non-drug interventions to reduce symptoms and improve quality of life for COPD patients.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!